Kylonova (Xiamen) Biopharmaceutical Co., Ltd.

Kylonova (Xiamen) Biopharmaceutical Co., Ltd. (Abbr.: Kylonova ) is mainly engaged in the research and development of new siRNA (small interfering nucleic acids) drugs and delivery platforms. Source (opens in a new tab)

Website

http://www.kylonova.com/en/

Headquarters

CN

Provider types

CDMO, API manufacturer